Key clinical point: Patients with peripheral artery disease should be evaluated not only for left ventricular systolic but also diastolic function in echocardiography.
Major finding: Multivariate analysis showed that peripheral artery disease was an independent predictor of left ventricular diastolic dysfunction (adjusted odds ratio. 1.77; P = .01).
Study details: The study enrolled 1,121 patients with preserved left ventricular systolic function.
Disclosures: The authors reported that they had no disclosures.
Yanaka K et al. J Cardiol. 2019 Feb 18. doi: 10.1016/j.jjcc.2019.01.011.
This Week's Must Reads
CVD Event Rates Among Adults with PCSK9 Inhibition, Cardiovasc Drugs Ther; ePub 2019 Feb 11; Colantonio, et al
Statin Adherence & Mortality in Patients with ASCVD, JAMA Cardiol; ePub 2019 Feb 13; Rodriguez, et al
Physician Monitoring & LDL-C Follow-Up Testing , Prev Med; 2019 Apr; Dansinger, Williams, et al
CVD Prevalence in HeFH After Statin Treatment, Atherosclerosis; ePub 2019 Feb 12; Perez-Calahorra, et al
Must Reads in Peripheral Vascular Disorders
PAD tied to higher prevalence of LV diastolic dysfunction, Yanaka K et al. J Cardiol. 2019 Feb 18. doi: 10.1016/j.jjcc.2019.01.011
Diabetic kidney disease, retinopathy associated with PAD in patients with foot ulcers, Megallaa MH et al. Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1287-92.
Smoking as PAD Risk Factor in African Americans, J Am Heart Assoc; ePub 2019 Jan 23; Clark III, et al
Effect of Statin Intensity on PAD Outcomes, Circulation; ePub 2018 Jan 12; Arya, et al